Q4 2015 Holdings
Filed 2016-02-12 | 78 holdings | $23.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Atricure Inc(ATRC) | COM | 04963C209 | $11.0M | 487,946 | 46.7% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $6.9M | 116,581 | 29.5% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $2.6M | 255,642 | 11.3% |
| Ascendis Pharma(ASND) | ADR ADDED | 04351P101 | $975.0K | 53,241 | 4.2% |
| Caredx Inc(CDNA) | COM | 14167L103 | $871.0K | 136,047 | 3.7% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $580.0K | 48,100 | 2.5% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $418.0K | 40,000 | 1.8% |
| Nxstage Medical Inc | COM | 67072V103 | $8.0K | 366,554 | 0.0% |
| Marinus Pharmaceuticals Inc | COM | 56854Q101 | $4.3K | 566,498 | 0.0% |
| Insulet Corp(PODD) | COM | 45784P101 | $4.0K | 106,018 | 0.0% |
| CTI Biopharma Corp | COM | 12648L106 | $3.9K | 3,195,381 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $3.6K | 148,369 | 0.0% |
| Vitae Pharmaceuticals Inc | COM | 92847N103 | $3.5K | 193,224 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $3.4K | 1,109,740 | 0.0% |
| Applied Genetic Technol Corp(2GT) | COM | 03820J100 | $3.2K | 157,192 | 0.0% |
| Cara Therapeutics Inc(CARAEUR) | COM | 140755109 | $2.9K | 169,331 | 0.0% |
| Biotelemetry Inc(BEATEUR) | COM | 090672106 | $2.8K | 235,645 | 0.0% |
| Achillion Pharmaceuticals(ACHNEUR) | COM | 00448Q201 | $2.6K | 236,500 | 0.0% |
| Insulet Corp | NOTE 2.000% 6/1 | 45784PAD3 | $2.5K | $2,407,000 | 0.0% |
| Masimo Corporation(MASI) | COM | 574795100 | $1.9K | 46,010 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $1.9K | 30,000 | 0.0% |
| Protalix Biotherapeutics Inc | NOTE 4.500% 9/1 | 74365AAB7 | $1.8K | $2,500,000 | 0.0% |
| Loxo Oncology Inc | COM | 548862101 | $1.8K | 61,737 | 0.0% |
| Synergy Pharmaceuticals | COM | 871639308 | $1.7K | 294,563 | 0.0% |
| Celyad | ADR | 151205200 | $1.6K | 30,000 | 0.0% |
| Derma Sciences Inc | COM PAR $.01 | 249827502 | $1.6K | 353,718 | 0.0% |
| Tobira Therapeutics Inc | COM | 88883P101 | $1.6K | 160,353 | 0.0% |
| Discovery Laboratories Inc | COM NEW | 254668403 | $1.6K | 7,467,032 | 0.0% |
| Cytrx Corp | COM PAR $.001 | 232828509 | $1.5K | 583,013 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $1.4K | 120,600 | 0.0% |
| Avalanche Biotechnologies in | COM | 05337G107 | $1.3K | 140,600 | 0.0% |
| Novadaq Technologies Inc | COM | 66987G102 | $1.3K | 101,841 | 0.0% |
| Spectranetics Corp | COM | 84760C107 | $1.2K | 79,812 | 0.0% |
| Nuvasive Inc | NOTE 2.750% 7/0 | 670704AC9 | $1.0K | $760,000 | 0.0% |
| Essa Pharma Inc | COM | 29668H104 | $1.0K | 228,500 | 0.0% |
| Zogenix Inc | COM | 98978L204 | $1.0K | 69,400 | 0.0% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $1.0K | 1,372,862 | 0.0% |
| Scynexis Inc | COM | 811292101 | $974 | 156,904 | 0.0% |
| Johnson and Johnson(JNJ) | COM | 478160104 | $966 | 9,400 | 0.0% |
| Neos Therapeutics Inc(NEOS) | COM ADDED | 64052L106 | $908 | 63,400 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $786 | 97,730 | 0.0% |
| Regulus Therapeutics Inc | COM | 75915K101 | $785 | 90,000 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $743 | 24,000 | 0.0% |
| Arena Pharmaceuticals Inc | COM | 040047102 | $725 | 381,600 | 0.0% |
| Cynapsus Therapeutics Inc | COM PAR NO PAR | 23257Y859 | $722 | 46,629 | 0.0% |
| Syneron Medical LTD | ORD SHS | M87245102 | $663 | 85,947 | 0.0% |
| Lipocine Inc | COM NEW | 53630X104 | $647 | 50,000 | 0.0% |
| Intec Pharma LTD Jerusalem SHS | SHS ADDED | M53644106 | $639 | 119,296 | 0.0% |
| Abeona Therapeutics Inc(ABEO1EUR) | COM | 00289Y107 | $611 | 181,818 | 0.0% |
| Alder Biopharmaceuticals Inc(ALDR1EUR) | COM | 014339105 | $595 | 18,000 | 0.0% |